Alex Wesselhoeft
Company: Orna Therapeutics
Job title: Founder & Director of Molecular Biology
Seminars:
Synthetic Circular RNA as a New Therapeutic Modality 1:30 pm
• Scalability of self-circularizing synthetic circular RNA (oRNA) • Assessing the immunostimulatory properties of oRNA • A new world of cap- and end-independent translation • Applying oRNA as a therapeutic modalityRead more
day: Day One
Roundtable Discussion: Discussing Regulatory Considerations for Next Generation RNA Therapeutics & Vaccines 12:00 pm
day: Day Two